Tid Tittel Kategori Vedlegg
17.06.2026
15:31
Mottatt søknad om strykning - -
17.06.2026
15:31
Received application for delisting - -
12.06.2026
11:41
EXACT Therapeutics minutes from Annual General Meeting June 12, 2026 -
1
04.06.2026
09:00
EXACT Therapeutics - webcast presentation -
1
01.06.2026
17:05
EXACT Therapeutics: Announces webcast regarding strategic intent to delist the company’s shares from listing on Euronext Growth, Oslo - -
29.05.2026
09:09
EXACT Therapeutics - Notice for Annual General Meeting 2026 -
1
29.05.2026
09:09
EXACT Therapeutics: Strategic intent to delist the company’s shares from listing on Euronext Growth, Oslo - -
09.04.2026
07:14
EXACT Therapeutics - Annual Report 2025 RAPPORT RAP
1
26.03.2026
12:00
EXACT Therapeutics AS: Share capital increase registered - -
13.03.2026
16:28
EXACT Therapeutics AS - Minutes from extraordinary general meeting on 13 March 2026 -
1
03.03.2026
14:15
EXACT Therapeutics - First patient dosed in Europe in Phase 2 trial in patients with locally advanced pancreatic cancer - -
27.02.2026
13:16
EXACT Therapeutics AS: Notice of extraordinary general meeting -
1
27.02.2026
08:54
EXACT Therapeutics AS: Warrants exercise - -
11.02.2026
08:00
EXACT Therapeutics: Investor presentation for the global investor call regarding the ongoing warrants exercise program -
1
06.02.2026
08:30
EXACT Therapeutics: Global investor call regarding the ongoing warrants exercise program - -
05.02.2026
13:19
EXACT Therapeutics: Correction of final warrants exercise date - -
05.02.2026
09:17
EXACT Therapeutics: Warrants exercise by leading shareholders and primary insiders INSIDEHANDEL INS
2
05.02.2026
08:30
EXACT Therapeutics: Exercise of Warrants by GE Medical Holding AB INFORMASJON INF -
27.01.2026
08:00
EXACT Therapeutics: Positive initial safety read-out from the Phase 2 ENACT trial in pancreatic cancer, triggering option to exercise warrants INFORMASJON INF -
08.01.2026
08:30
EXACT Therapeutics’ Phase 2 trial in pancreatic cancer patients to be presented at the 2026 ASCO Gastrointestinal Cancers Symposium - -
25.11.2025
12:57
EXACT Therapeutics to present company update -
1
24.11.2025
08:25
EXACT Therapeutics AS: New option program and receipt of share options by primary insiders INSIDEHANDEL INS
1